One microcap biotech is charging headfirst into treacherous IPO waters, jumping to Nasdaq with modest raise
It’s a tough market right now for biotech IPOs, but one small company is taking the public leap Friday with a modest initial offering.
Blue Water Vaccines raised $20 million in its IPO, pricing shares at $9 apiece late Thursday afternoon. The Cincinnati-based company will use the money primarily to advance a slate of preclinical programs toward IND studies and boost manufacturing capabilities, it reported in its S-1 filing.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.